Patent ID: 11884725
Assignee: AMPSOURCE BIOPHARMA SHANGHAI INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 14:
15. The pharmaceutical composition according to claim 14, further comprising a second antibody that specifically binds to a receptor or a ligand or a nucleic acid encoding the second antibody, wherein the receptor or the ligand is selected from PD-1, PD-L1, PD-L2, LAG-3, TIGIT, VISTA, CTLA-4, OX40, BTLA, 4-1BB, CD96, CD27, CD28, CD40, LAIR1, CD160, 2B4, TGF-R, KIR, ICOS, GITR, CD3, CD30, BAFFR, HVEM, CD7, LIGHT, SLAMF7, NKp80, B7-H3 or any combination thereof.